Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

washingtonexaminer.com - J.D. Hayworth - Americans want big pharma reform. Candidates should deliver
Americans want big pharma reform. Candidates should deliver
Washington Examiner

Having spent 12 years on Capitol Hill, I know just how rare it is to find an issue with real bipartisan consensus. That's why when a new national survey shows 94% of voters blame pharmaceutical companies for the high cost of healthcare, it demands…

chron.com - Royalty Pharma: Q1 Earnings Snapshot
Royalty Pharma: Q1 Earnings Snapshot
Chron

NEW YORK (AP) — NEW YORK (AP) — Royalty Pharma (RPRX) on Wednesday reported first-quarter profit of $295 million. On a per-share basis, the New York-based company said it had profit of 53 cents. Earnings, adjusted for non-recurring…

thehindubusinessline.com - Indian industry led by pharma to invest $20.5 billion in the US
Indian industry led by pharma to invest $20.5 billion in the US
BusinessLine

Indian industry, led by pharmaceutical companies, shared plans of investing $20.5 billion in the US at the 2026 SelectUSA Investment Summit, reinforcing the growing role of Indian companies as investors and partners in the US economy, per a…

newswire.ca - Innocan Pharma LPT-CBD is featured in Pain Medicine News
Innocan Pharma LPT-CBD is featured in Pain Medicine News
CNW

The article highlights expert discussion presented at PAINWeek 2025 regarding Innocan's LPT-CBD. LPT-CBD is designed to enable prolonged CBD release into the bloodstream, enhance bioavailability, and support once-monthly subcutaneous…

bloomberg.com - Saikat Das - Sun Pharma Explores Funding Mix for $12 Billion Organon Deal
Sun Pharma Explores Funding Mix for $12 Billion Organon Deal
Bloomberg

Global lenders to Sun Pharmaceutical Industries Ltd. are weighing multiple financing options for its proposed $12 billion acquisition of New York-listed healthcare company Organon & Co., according to people familiar with the matter. The Indian…

fool.com - Motley Fool Transcribing - Royalty Pharma (RPRX) Q1 2026 Earnings Transcript
Royalty Pharma (RPRX) Q1 2026 Earnings Transcript
The Motley Fool

Wednesday, May 6, 2026 at 8:00 a.m. ET Chief Executive Officer and Chairman of the Board — Pablo Legorreta Chairman, Partnering and Investments — Christopher Hite EVP, Head of Research and Investments — Marshall Urist EVP…

mumsnet.com - Leaving pharma for teaching, what is the workload really like?
Leaving pharma for teaching, what is the workload really like?
Mumsnet

Please or to access all these features Chat with other users about all things related to working life on our Work forum. MammyofTwoB · Today 11:06 I'm thinking of leaving my job (lab analyst at a pharma company) to become a teacher. I've…

counterpunch.org - Dean Baker - Purdue Pharma Bites the Dust: Can We Learn Anything?
Purdue Pharma Bites the Dust: Can We Learn Anything?
Home - CounterPunch.org

May 6, 2026 Dean Baker Suppose there was an explosion at an oil refinery that killed hundreds of people. Presumably, there would be a major investigation to determine what went wrong and how to prevent a similar accident in the future. But it's…

fortune.com - Josh Boak - That alone should win us the midterms': Trump wants voters to ignore higher costs, giant pharma profits and focus on drug prices
That alone should win us the midterms': Trump wants voters to ignore higher costs, giant pharma profits and focus on drug prices
Fortune

White House economists estimate that President Donald Trump's deals with pharmaceutical companies to drop some of their U.S. prescription drug prices to what they charge in other countries could save $529 billion over the next 10 years. The…

newswire.ca - High Tide Inc. - High Tide Reports Record Quarterly Distribution of 7.6 Tonnes of Medical Cannabis Through Remexian Pharma GmbH, Accelerating German Market Leadership
High Tide Reports Record Quarterly Distribution of 7.6 Tonnes of Medical Cannabis Through Remexian Pharma GmbH, Accelerating German Market Leadership
CNW

CALGARY, AB, May 6, 2026 /CNW/ - High Tide Inc. ('High Tide' or the 'Company') (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today…

thehindubusinessline.com - Indian firms commit $20.5 billion investment in US; Pharma dominates with $19.1 billion
Indian firms commit $20.5 billion investment in US; Pharma dominates with $19.1 billion
BusinessLine

Indian investments in the United States at the 2026 SelectUSA Investment Summit reach a record $20.5 billion as industry leaders cement their roles as primary partners in the American economy, according to the US Embassy & Consulates in India. The…

law360.com - Jeff Overley - DC Circ. Judge Jabs Pharma Atty For 10 Minutes In Price Fight
DC Circ. Judge Jabs Pharma Atty For 10 Minutes In Price Fight
Law360

The first D.C. Circuit showdown in widespread drug pricing litigation Tuesday appeared unlikely to deliver a badly needed win to the pharmaceutical industry, as a top manufacturer's attorney faced a cool... To view the full article, register now.

cyprus-mail.com - Innovative European LIFE Pharma-Detox project, coordinated by Medochemie, under way
Innovative European LIFE Pharma-Detox project, coordinated by Medochemie, under way
Cyprus Mail

With steady progress and growing international recognition, the European project LIFE Pharma-Detox continues to advance under the coordination of Medochemie, setting a new benchmark for pharmaceutical waste management. As part of the project's…

marketbeat.com - Innate Pharma (IPHA) Expected to Announce Quarterly Earnings on Wednesday
Innate Pharma (IPHA) Expected to Announce Quarterly Earnings on Wednesday
MarketBeat

Innate Pharma (NASDAQ:IPHA - Get Free Report) is expected to release its Q1 2026 TU results before the market opens on Wednesday, May 13th. Analysts expect Innate Pharma to post earnings of ($0.3492) per share and revenue of $2.7160 million for the…

marketbeat.com - Urogen Pharma (NASDAQ:URGN) Trading Up 14% on Better-Than-Expected Earnings
Urogen Pharma (NASDAQ:URGN) Trading Up 14% on Better-Than-Expected Earnings
MarketBeat

Shares of Urogen Pharma (NASDAQ:URGN - Get Free Report) were up 14% on Wednesday following a better than expected earnings announcement. The stock traded as high as $26.94 and last traded at $27.1690. Approximately 1,730,628 shares traded hands…

Receive a Daily briefing on Pharma Industry News

Get Started